HELENA LONGFELLOW: Open Payments
NPI 1275131203 · MAHOMET, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 19 payments from 9 companies in 2025. Trend: 2023 $405 · 2024 $616 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $239 |
| Axsome Therapeutics, Inc. | 1 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| Amgen Inc. | 1 | $18 |
Products named: VRAYLAR, Auvelity, CAPLYTA, UBRELVY, Jornay PM, LEQVIO, ZENPEP, JARDIANCE.
Industry payments across IL — which companies pay providers there.
